SCR-LIP-000605 · Claim · machine-readable JSON →
Prevalence estimates suggest lipedema is common among women, far exceeding recorded diagnoses, although estimates vary widely.
General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 8 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (8)
- Prevalência e fatores de risco para lipedema no Brasil — Amato et al. (2022) ✓ verified — consistent · cross sectional · 2022 · reading confidence: high
Population study using a validated questionnaire (cutoff >=12, AUC 0.8615, sensitivity 0.46, specificity 0.88) estimated 12.3% prevalence in women aged 18-69, about 8.8 million women.
The article applies a validated screening tool to estimate high lipedema prevalence in a large population, directly demonstrating that screening instruments can identify suspected lipedema cases and supporting the notion of substantial undi - Lipedema: A Call to Action! — Buso et al. (2019) ✓ verified — consistent · review · 2019 · reading confidence: high
“Prevalência mínima: 1:72.000 na população geral (Child et al.), considerado subestimação — estudo alemão com 62 mulheres profissionais detectou lipedema em 39% (todos os estágios), 9,7% para apresentação moderada a grave”
Review: minimum prevalence 1:72,000 considered an underestimate; a study of 62 professional women found lipedema in 39% (9.7% moderate to severe).
This narrative review explicitly states that lipedema is underdiagnosed and misdiagnosed, and calls for increased awareness and better understanding of its clinical presentation to improve diagnosis, directly supporting the affirmative dire - Lipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“Prevalência estimada de 6–11% em mulheres na população geral; prevalência mundial ~10% — subestimada por ausência de código ICD-10 nos EUA e falta de biomarcador diagnóstico validado”
Review: estimated prevalence 6-11% in women, underestimated by lack of a US ICD-10 code and of a validated diagnostic biomarker.
This systematic review directly addresses underrecognition and diagnostic challenges in lipedema, supporting the affirmative direction of the question, though it does not specifically evaluate screening tools. - Lipedema: What we don’t know — van la Parra et al. (2023) ✓ verified — consistent · review · 2023 · reading confidence: high
“prevalência estimada em até 39% na população geral alemã (Lipedema-3 trial) — doença significativamente subdiagnosticada”
Review cites prevalence of up to 39% in a German population sample, calling lipedema significantly underdiagnosed.
This narrative review directly addresses underdiagnosis of lipedema and the diagnostic challenges, supporting the affirmative direction of the question. It does not specifically evaluate screening tools but highlights the diagnostic gap and - Observational Study of Ultrasound-Assisted Liposuction for Lower Limb Lipedema on 191 Female Patients — Hersant et al. (2026) ✓ verified — consistent · cohort · 2026 · reading confidence: high
“Lipedema, a chronic condition affecting 11% of women, causes abnormal fat buildup in the lower limbs, leading to disproportionate body shape and functional problems. Often misdiagnosed, its cause is unclear”
Liposuction cohort introduction states lipedema affects 11% of women and is often misdiagnosed.
The article briefly mentions that lipedema is often misdiagnosed (supporting the underdiagnosis aspect of the question) but does not address screening tools; its primary focus is on surgical treatment outcomes, making it only tangentially r - Lipedema Research—Quo Vadis? — Ernst et al. (2023) ✓ verified — contextual · review · 2023 · reading confidence: high
“Prevalência mundial estimada em 11% entre mulheres — dado ampliado por subdiagnóstico, mas com limitação diagnóstica reconhecida pelos autores”
Review estimates worldwide prevalence of about 11% among women, noting underdiagnosis and acknowledged diagnostic limitations affect the figure.
The review mentions underdiagnosis ('subdiagnóstico') as a factor inflating prevalence estimates, which provides contextual support for underdiagnosis, but it does not directly study or evaluate any screening tools; its primary focus is mol - Lipedema: A Relatively Common Disease with Extremely Common Misconceptions — Buck & Herbst (2016) ✓ verified — consistent · review · 2016 · reading confidence: high
“Lipedema afeta ~1 em 9 mulheres adultas; apesar da prevalência estimada, poucos médicos reconhecem a constelação de sinais e sintomas para diagnosticá-lo corretamente”
Review: lipedema affects about 1 in 9 adult women, yet few physicians recognise the constellation of signs and symptoms needed to diagnose it.
This is a narrative review article that highlights underdiagnosis of lipedema and the need for better diagnostic tools, directly supporting the question's affirmative direction, but provides no original screening tool validation data. - Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) ✓ verified — contextual · cross sectional · 2025 · reading confidence: moderate
“Despite its considerable impact on patients' quality of life, it remains underdiagnosed.”
Survey linking lipedema with hypermobility (44% in adulthood) more often than lymphedema; authors state lipedema remains underdiagnosed despite its impact on quality of life.
The article explicitly states lipedema remains underdiagnosed, providing context relevant to the question, but its primary aim concerns pathophysiological overlap with HSD rather than evaluating a screening tool; the instrument was a non-va
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? consistent
- Is lipedema underdiagnosed, misdiagnosed, or diagnosed late? consistent
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000004